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Abstract
A superposition/convolution GPU-accelerated dose computation algorithm (the Calculator) has been recently incorporated into commercial software. The algorithm requires
validation prior to clinical use. Three photon energies were examined: conventional 6
MV and 15 MV, and 10 MV ﬂattening ﬁlter free (10 MVFFF). For a set of IMRT and
VMAT plans based on four of the ﬁve AAPM Practice Guideline 5a downloadable datasets, ion chamber (IC) measurements were performed on the water-equivalent phantoms. The average difference between the Calculator and IC was

0.3  0.8% (1SD).

The same plans were projected on a phantom containing a biplanar diode array. We
used the forthcoming criteria for routine gamma analysis, 3% dose–error (global (G)
normalization, 2 mm distance to agreement, and 10% low dose cutoff). The c (3%G/
2 mm) average passing rate was 98.9  2.1%. Measurement-guided three-dimensional
dose reconstruction on the patient CT dataset (excluding the Lung) resulted in a similar
average agreement rate with the Calculator: 98.2  2.0%. The mean c (3%G/2 mm)
passing rate comparing the Calculator to the TPS (again excluding the Lung) was
99.0  1.0%. Because of the signiﬁcant inhomogeneity, the Lung case was investigated separately. The calculator has an alternate heterogeneity correction mode that
can change the results in the thorax for higher-energy beams (15 MV). As this correction is nonphysical and was optimized for simple slab geometries, its application leads
to mixed results when compared to the TPS and independent Monte Carlo calculations,
depending on the CT dataset and the plan. The Calculator vs. TPS 15 MV Guideline 5a
IMRT and VMAT plans demonstrate 96.3% and 93.4% c (3%G/2 mm) passing rates
respectively. For the lower energies, which should be predominantly used in the thoracic region, the passing rates for the same plans and criteria range from 98.6 to 100%.
Overall, the Calculator accuracy is sufﬁcient for the intended use.
PACS
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1 | INTRODUCTION

ET AL.

adapted for fast execution on the graphics processing unit (GPU)
card(s). As with all implementations of S/C methods, the calculation

It is the current standard of practice in the United States that for

consists of three steps: ﬂuence calculation, total energy released per

each radiotherapy treatment course involving intensity modulated,

unit mass (TERMA) calculation, and, ﬁnally, superposition.

inversely planned dose delivery (IMRT/VMAT), a patient-speciﬁc

The ﬂuence calculation is responsible for simulating radiation

quality assurance procedure has to be performed to ensure that the

transport within the linear accelerator treatment head. There are

calculated dose distribution is reasonably accurate.1 A simple point

separate sources used to model primary, extra focal (scatter), and

dose veriﬁcation is considered sufﬁcient in conventional (forward-

electron contamination radiation. The primary and extrafocal sources

planning) therapy.2 Acknowledging the complexity and temporal nat-

each have their own spectrum and arbitrary radial intensity proﬁle.

ure of the dose calculation and delivery of modulated beams, dose

Jaws and MLC characteristics, including properties such as MLC ton-

comparison has to be more extensive. Historically, patient speciﬁc

gue-and-groove thickness and MLC leaf end curvature, are

IMRT QA was performed by projecting the treatment plan on a

accounted for explicitly.

phantom containing a dosimeter and comparing the measured sam-

In the next step, ﬂuence is transported through the patient to

ple of the 3D dose distribution with calculations.3 As the inversely

compute primary energy released in the volume (TERMA). The mate-

planned techniques matured and became the mainstay of radiother-

rial composition of the patient volume is determined using the CT

apy, alternative dose veriﬁcation techniques started to be actively

dataset along with a user-provided CT-to-relative electron density

explored.

device

(ED) conversion table. From relative electron density, other material

(EPID)-based dosimetry,4,5 calculation-based reconstruction from the

properties are computed by interpolation among nine predeﬁned

accelerator log ﬁles,6,7 including harvesting aperture shapes (but not

materials, one of which is water. The TERMA calculation uses

ﬂuence) from the EPID,8 or just a straightforward recalculation by an

energy-dependent (16 bins) mass attenuation coefﬁcients for the

Those

included

9–13

electronic

portal

imaging

Each method has its advantages and

appropriate material,20 while electron density is used to attenuate

disadvantages, and none is capable of catching every possible mode

the primary ﬂuence through the patient along the heterogeneity-cor-

of failure,10 including catastrophic events.

rected ray-trace path. TERMA is calculated every 2° for VMAT

independent dose engine.

In this article, we critically examine and validate a fast, indepen-

plans.

dent 3D dose calculator as an additional tool that potentially could

Finally, the superposition step spreads the TERMA by the

be incorporated in the IMRT/VMAT QA process. This calculator is

energy deposition kernel to determine the ﬁnal dose at each

the dose engine used in the commercial products (Sun Nuclear Corp.,

point.19 The kernel is derived from high resolution (1 mm, 1°)

Melbourne, FL, USA) for purely calculational (DoseCHECK) or empiri-

Monte Carlo (MC) simulations in the water phantom. A cumulative-

cally guided (PerFRACTION) dose reconstruction. For the former,

cumulative kernel is used to minimize voxelization effects.18 The

the DICOM RT Plan from the primary treatment planning system

energy deposition kernel scales with electron density, which differ-

(TPS) serves as the input for the veriﬁcation dose calculation on the

entiates the superposition approach from the traditional convolu-

patient CT dataset. In the latter, the aperture shapes recorded by

tion.17 The kernel’s angular dependence is discretized using a

the EPID during beam delivery are used to generate the MLC control

collapsed cone approximation,21 and both kernel tilting and beam

points. Simultaneously, corresponding monitor unit and angle pro-

hardening are accounted for. The superposition calculation for

gressions are harvested from the accelerator log ﬁles for dose calcu-

VMAT is performed every 5°, which still allows for acceptable accu-

lation. A common step to both the calculational and the semi-

racy of the overall calculation.17 As TERMA calculations are sub-

empirical approaches is dose calculation by a Superposition/Convolu-

stantially faster than superposition calculations, using a high TERMA

tion (S/C) technique. Obviously, the accuracy of the dose calculation

but low superposition angular resolutions increases the speed of

engine employed in these products is of paramount importance for

VMAT calculations.17

their clinical performance and deserves a thorough investigation.
Experimental validation of the algorithm is the only goal of this
manuscript. The data from this manuscript was used in the Sun

2.A.2 | Input data

Nuclear Corp. White Paper.14 We do not attempt to weigh in on an

The Calculator comes preconﬁgured with standard beam models for

ongoing discussion15,16 of the relative merits of measurement-based

each machine class. For example, the energy spectra/beam proﬁles

vs. software-based patient-speciﬁc IMRT QA methods.

for the TrueBeam linac used in this work (Varian Medical Systems,
Palo Alto, CA, USA) are based on average measurements for ﬁve

2 | METHODS

machines of the same class. The same is true for the majority of relative output factors (Scp). However, for the small ﬁelds (≤ 4 cm) the

2.A | Calculator description

output factors from Kerns et al.22 were used. The user has to supply

2.A.1 | Dose calculation algorithm

the local CT number-to-ED conversion table and the absolute output

The approach was originally developed and described in detail by

data, a set of DICOM CT and corresponding DICOM RT Plan and

Jacques et al.17 It is a variant of a S/C style dose calculation18–20

DICOM RT Structure objects are required. The structures determine

per monitor unit under the reference conditions. For patient-speciﬁc
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the extent of the dose reporting volume. Also, if the density override

recommendations. To achieve similar agreement in Pinnacle, the cal-

information is present in the Structure object, it is used in dose

culation mode had to be switched to the homogeneous water phan-

calculations.

tom. Otherwise, a synthetic CT phantom of unit density is treated in
Pinnacle as being slightly different from water, due to the CT to
material assignment method.26 After proper reference dose was con-

2.B | Validation

ﬁrmed, the Pinnacle and Calculator dose grids (2 mm voxel size)

The main goal of this paper is independent validation of the just

were loaded in 3DVH software v. 3.3 (Sun Nuclear Corp) and com-

described algorithm. To cover a reasonably wide range of energies

pared using gamma analysis using 2% (global normalization) dose–er-

and different beam types, three photon energies were examined:

ror and 2 mm distance to agreement criteria, with low-dose cut-off

conventional 6 MV and 15 MV, and 10 MV ﬂattening ﬁlter free

at 10% of the maximum (2%G/2 mm/10%).

(10 MVFFF). The validation was performed in a deliberate fashion,
gradually increasing the complexity of the tests in terms of radiation

2.B.2 | Slab inhomogeneities

ﬁelds (from basic shapes to IMRT/VMAT), analysis dimensionality
(from point doses to 2D to 3D dose sampling), and dataset hetero-

The calculator has two modes for handling signiﬁcant inhomo-

geneity (from homogeneous phantoms to thoracic CTs).The strategy

geneities (e.g., lung), requiring two separate beam models. The basic

included a number of steps similar to commissioning of a primary

S/C approach was described above. Alternatively, an additional cor-

23

TPS,

rection known as Heterogeneity-Compensated Superposition (HCS)

albeit abbreviated:

27

can be applied. It relies on the patient density near the material

(1) Dose distributions for simple square ﬁelds were compared on

interfaces being modiﬁed (ﬁltered) in a position and direction sensi-

the water phantom between the Calculator and the primary TPS

tive manner, allowing the dose to be changed compared to the stan-

(Pinnacle v. 9.8, Philips Medical Systems, Fitchburg, WI);

dard S/C approach. Application of this correction approximately

(2) Central axis percentage depth doses (PDD) were compared on a
lung-simulating slab phantom between Pinnacle, the Calculator,
and Monte Carlo (MC) simulations;
(3) IMRT/VMAT plans generated on the AAPM Practice Guideline
5a23 datasets were recalculated on the phantoms. Point doses

doubles the calculation time.
Depth-dose curves were extracted from Pinnacle, standard Calculator, HCS Calculator, and Monte Carlo (MC) calculations for
2 9 2, 5 9 5, and 10 9 10 cm2 ﬁelds on a wide slab phantom consisting of 5 cm of water, followed by 5 cm of lung (0.3 g/cm3), and

were measured with an ion chamber in the phantoms and com-

20 cm of water. All PDDs were normalized beyond their respective

pared to the doses predicted by the Calculator;

dmax, at a 2 to 3 cm depth, depending on the beam energy.

(4) The Calculator dose distributions for selected plans on a homo-

Monte Carlo calculations were performed with PRIMO, a

geneous cylindrical phantom were compared against a biplanar

radiotherapy graphical interface to PENELOPE code.28 Manufac-

diode array (Delta4) measurements for a limited number of

turer-provided IAEA-compliant phase space ﬁles for the TrueBeam

points (the diodes’ locations);

accelerator29 were used in lieu of modeling the accelerator head

(5) The 3D Calculator dose on the patients’ CTs was compared to

above the movable jaws. The current version of those ﬁles provides

the 3D measurement-guided dose reconstruction on the same

a phase space on a horizontal plane 27 cm downstream from the

datasets;

source. The number of histories was sufﬁcient to achieve 1% statisti-

(6) Finally, all calculated 3D patient dose distributions were com-

cal uncertainty (two standard deviations) at the dose level above

pared between the Calculator and the primary TPS, as would

50% of the maximum in the phantom. An in-house script was writ-

ultimately be done in the clinic.

ten to convert PRIMO ASCII dose ﬁles into DICOM RT-compliant
dose objects. The PRIMO simulations were validated against Pinna-

2.B.1 | Basic beams on the water phantom

cle for the 10 9 10 cm2 ﬁelds on the water phantom, at the 2%/
2 mm level.

The dose distributions on the synthetic CT phantom of unit density
were compared to the primary TPS for a series of open square ﬁelds
(5 9 5, 10 9 10, and 20 9 20 cm2) and a 3 9 3 cm2 MLC-deﬁned
aperture in the middle of a 10 9 10 cm2 jaw opening. The Pinnacle
Collapsed Cone Convolution

24,25

beam model in our system gener-

2.B.3 | IMRT/VMAT Planning and delivery
All measurements were done on a TrueBeam v 2.0 linear accelerator
equipped with a 120-leaf Millennium MLC (Varian Medical Systems).

ally agrees with water scans for basic ﬁelds to within 1%, and thus

The IMRT and VMAT plans were developed based on the Guide-

the TPS was used as the reference to facilitate easy full 3D dose

line 5a Report library of test plans.23 They included four realistic

comparison. Also, it is useful to compare the basic beam data with

plans from the available downloadable datasets: Anal, Head and

Pinnacle, as ultimately the modulated dose distributions are com-

Neck (H&N), Abdomen and Lung. The concept behind these Guide-

pared to it as well. The absolute point dose under the TPS reference

line 5a cases is to provide challenging but clinically relevant goals,

conditions, as generated by the Calculator, was found to be within

with large targets and tight constraints, resulting in highly modulated

0.2% of the expected (input) dose, thus satisfying the Guideline 5a23

plans pushing the accuracy limits of the TPS calculation algorithms.
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similar to the pilot study described by Nelms et al.

ET AL.

opposed 10 9 10 cm2 ﬁelds and minimizing the difference with the
primary TPS in the central portion of the irradiated area. Gamma

Both VMAT (Pinnacle SmartArc31,32) and static gantry, seg33

analysis with 3%G/2 mm/10% criteria was used as the primary met-

mented IMRT (Pinnacle Direct Machine Parameters Optimization )

ric here and later in this study. Results with 2%G/2 mm criteria are

plans were created for each case. Optimization was done for the

also presented for comparison, as warranted. Gamma analysis was

6 MV beams, and other energies were simply recalculated for the

performed using the Delta4 software, with the Calculator DICOM RT

same control points (CP). The H&N and Anal VMAT plans used two

dose grid loaded as reference dose.

arcs, while the remaining plans used one. The VMAT plans were calculated with 2° angular CP increment. The IMRT plans used seven
to nine equidistant gantry angles. Three of four plans (except the
Abdomen), had targets too large to be encompassed for conventional

2.B.6 | The Calculator vs. 3D measurement-guided
dose reconstruction on patient CT

IMRT with a single set of the MLC carriage positions, due to the lim-

Following the measurements with the ArcCHECK (AC) dosimeter

itations of the maximum leaf extension. They were instead planned

(Sun Nuclear Corp.), measurement-guided dose reconstruction on

with the “wide-ﬁeld” IMRT technique, where the leaves are allowed

the patients’ datasets was performed, using the AC-based planned

to nearly close inside the treatment ﬁeld, not necessarily under the

dose perturbation (ACPDP) method.34–37 The AC measurements and

X jaws, but those leaf abutment points move across the ﬁeld from

the primary TPS (Pinnacle) dose grid were used as the required

segment to segment to avoid excessive exposure at any one location

ACPDP inputs. The ACPDP dose was loaded as the reference in

in the patient. In all cases, a uniform 2.5 mm dose grid resolution

3DVH software,37 and the Calculator dose as the comparison. Both

was used for both the TPS and the Calculator.

Pinnacle and the Calculator used the CT number-to-density conversion tables derived from the same phantom scan. However, the

2.B.4 | The Calculator vs. point dose measurements

physical density values were speciﬁed for Pinnacle and electron density for the Calculator. The ACPDP method generates a 3D dose grid

For the three of four cases (excluding the Lung), the plans were pro-

on a patient dataset. However, it has no knowledge of the (variable)

jected on the homogeneous 20 9 20 9 20 cm3 Plastic Water Cube

density of the patient and relies on the primary TPS to account for

phantom (CIRS Inc., Norfolk, VA, USA). Point doses in the high-dose,

inhomogeneities. For the test plans excluding the Lung dataset, the

low-gradient regions were measured with a 0.125 cm3 Model

density variations do not pose a problem beyond possible minor dis-

TN31010 (PTW, Freiburg, Germany) ion chamber (IC). The chamber

crepancies. However, with the large low density heterogeneities,

was cross-calibrated in a 10 9 10 cm2 ﬁeld against the expected pri-

there is no guarantee that the different dose calculation algorithms

mary TPS dose prior to every measurement session. The chamber

would agree. Therefore, the Lung case was excluded from the

volume was drawn as a region of interest and the corresponding

ACPDP analysis and was investigated separately as described in the

mean dose was used for comparisons.

following sections.

Unlike the previous three plans, the Lung plan was recalculated

The same 3%G/2 mm gamma analysis criteria were used, supple-

on a heterogeneous anthropomorphic Thorax Phantom (modiﬁed

mented by 2%G/2 mm data. Since the discrepancies in the buildup

Model 002LFC; CIRS Inc.),34 with the isocenter paced at the middle

region are expected, and are effectively ignored in the traditional

of the spherical target. The phantom is based on a Plastic Water

phantom measurements by the virtue of the active volume placement

cylinder with an approximately elliptical cross-section. The overall

at depth, the analyzed volumes here and in the next section were ﬁl-

dimensions are 30 cm 9 30 cm 9 20 cm. The phantom contains

tered to exclude the outermost 7 mm of the body on the CT datasets.

two cylindrical “lungs” made of epoxy resin 0.21 g/cm3 in density.
The right lung can accommodate a 4 cm diameter spherical Plastic
Water target. The target and a number of other locations in the
phantom accept an A1SL 0.05 cm3 IC (Standard Imaging Inc., Mid-

2.B.7 | The Calculator vs. primary TPS on the
patient CT (Not including Lung)

dleton, WI, USA). The IC measurements were performed at two

The 3D Calculator doses on the patients’ datasets were directly

points: in the target sphere and in the “mediastinum”, the latter

compared to the corresponding Pinnacle dose distributions using the

representing a point well within the homogeneous portion of the

same methodology as described above. This conﬁguration represents

phantom.

the intended use of the Calculator. The Lung case is not included in
this comparison, to isolate differences in accounting for hetero-

2.B.5 | The Calculator vs. biplanar diode array
(homogeneous phantom)
In the next step, the Calculator dose distributions were compared to

geneities.

2.B.8 | The Calculator vs. primary TPS (Lung)

the Delta4 (ScandiDos AB, Uppsala, Sweden) measurements, sam-

Additional comparisons were made for the Lung plan to better

pling the dose volume with two orthogonal detector planes. The

understand the differences, and their practical signiﬁcance, between

daily correction factor was determined by irradiating two parallel-

the two versions of the Calculator heterogeneity corrections. Unlike
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with the previous three datasets, special tests were done for the
Lung plan. In addition to comparisons on the patient dataset, the

77

3.B | Slab inhomogeneities

plans were recalculated on the Thorax phantom with Pinnacle, no-

The central axis PDDs on the lung slab phantom for a small

HCS, and HCS versions of the Calculator. The phantom provides

(2 9 2 cm2) ﬁeld are shown in Fig. 2. For the 15 MV beam

clear-cut interfaces and uniform low-density regions, which were

(Fig. 2(a)) one can see the difference in lung dose between Pinna-

expected to emphasize the differences between various algorithms.

cle, Non-HCS Calculator, and HCS-corrected Calculator. The HCS

Comparisons with MC were also performed. Unfortunately, it is

correction improved agreement with Pinnacle and MC in the simple

not practical to recalculate segmented beams with PRIMO. Instead,

geometry, as reported previously.27 For the lower energies

we created a simple 5-beam coplanar plan which could be calculated

(Figs. 2(b) and2(c)), the difference between Pinnacle and the stan-

on the Thorax phantom with identical parameters with every S/C

dard Calculator mode in the inhomogeneity was minimal (< 1.3%

algorithm and MC. All beams were equally weighted and the MLC

and 0.7% of Dmax for 10 MVFFF and 6 MV, respectively), and both

apertures surrounded the 4 cm diameter spherical target with a

were sufﬁciently close to MC. Therefore, the effect of the HCS

0.7 cm margin. The relative MC calculations were normalized to the

correction was not further studied for those energies. The larger

isocenter dose measured with an IC. The resulting dose grids were

ﬁelds (not shown) exhibited the same trends but to a smaller

compared in 3DVH software.

degree.

3. | RESULTS

3.C | The Calculator vs. point dose measurements
For the point doses in the homogeneous phantoms or portions

3.A | Basic beams on the water phantom

thereof (e.g., excluding the target location in the Thoracic phantom),

For all beams and energies the average c (2%G/2 mm) agreement

the mean Calculator vs. the IC difference was

beyond dmax was 99.3  1.3% (1 SD). The only plans having < 100%

The range was from

agreement were the 20 9 20 cm2 ﬁelds for 10 MVFFF and 15 MV

Guideline 5a Lung case as delivered to the Thorax phantom, the

(96.7 and 97.9%, respectively) and the MLC-deﬁned 3 9 3 cm2

15MV IMRT and VMAT plans showed 2.8 and 4.0% difference from

0.3  0.8% (1 SD).

2.0 to 1.0%. For the plans based on the

15 MV ﬁeld. To emphasize the areas of disagreement for the

the IC in the target respectively. Pinnacle doses at the same point

20 9 20 cm2 ﬁelds, the error maps in Fig. 1 are based on the more

were within 1.4% of the IC. With the HCS correction applied, the

sensitive gamma analysis with local (L) dose–error normalization, c

disagreement was reduced to

(2%L/2 mm). It is clear that for the larger ﬁelds the beam proﬁles

and VMAT plans, respectively, while the change in the homogeneous

disagree somewhat, particularly with increasing depth. For the

portion of the phantom was minimal. The ﬁndings for the Lung plans

10 MVFFF beam, the Calculator proﬁle and Pinnacle straddled the

with both lower energies were unremarkable at both measurement

experimental curve, although the Calculator was closer. On the other

points in the Thorax phantom.

0.7% and 1.6% for the 15 MV IMRT

hand, Pinnacle showed better agreement with the measurement for
15 MV. The disagreement for the MLC-deﬁned 3 9 3 cm2 15 MV
ﬁeld inside the 10 9 10 cm2 jaw opening is due entirely to the 2.9%
difference in computed outputs for a partially obscured distributed

3.D | The Calculator vs. biplanar diode array
(homogeneous phantom)

secondary source (all comparisons were done in absolute dose

The average c (3%G/2 mm) and c (2%G/2 mm) passing rates of the

mode). Pinnacle and Calculator calculation results straddled our

Calculator against the Delta4 measurements were 98.9  2.1% and

experimental output value, with Pinnacle being 0.7% high and the

96.1  6.4% respectively. The Calculator produced c (3%G/2 mm)

Calculator 2.2% low, both reasonable values. The Pinnacle dose

agreement rates with the Delta4 measurements above 95% in all the

22

matched exactly the median of measured values from Kerns et al.

studied cases but two, and all were above 90% (Fig. 3). Both lower

Scaling the Calculator dose accordingly lead to a 100% agreement at

passing rates are associated with the 6 MV Anal case plans (94.8%

the 2%L/2 mm level beyond the dmax.

for VMAT and 91.4% for IMRT) (Fig. 3)

F I G . 1 . Gamma analysis (2%L/2 mm)
error maps (inserts) between Pinnacle and
SNC calculator, and normalized cross-plane
dose proﬁles at 20 cm depth for 10MVFFF
(a) and 15 MV (b) 20 9 20 cm2 ﬁelds. Ion
chamber (IC) proﬁles are also included for
comparison. Red and blue pixels are where
the Calculator dose is above and below
Pinnacle respectively.
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F I G . 3 . Frequency distribution of the c-analysis passing rates
comparing the Calculator to the Delta4 for all Guideline 5a test
cases and energies. N = 24.

F I G . 2 . Central axis PDDs on the lung slab phantom for the
2 9 2 cm2 ﬁeld: 15MV (a), 10 MVFFF (b), and 6MV (c).

3.E | The Calculator vs. 3D measurement-guided
dose reconstruction (not including lung)

F I G . 4 . Frequency distribution of the c-analysis passing rates
comparing the Calculator to ACPDP measurement-guided dose
reconstruction on the patient datasets for Guideline 5a test cases
excluding the Lung (all energies). N = 18.

In the next step, the agreement between the measurement-guided
dose reconstruction on the patient datasets using the ACPDP
method, and the Calculator followed the same trend as the direct
comparison on the homogeneous phantom (compare Figs. 4 and 3).
The Guideline 5a Lung plans were excluded from the comparison.

3.F | The Calculator vs. primary TPS on the patient
CT (not including lung)

The average c (3%G/2 mm) and c (2%G/2 mm) passing rate were

The mean c (3%G/2 mm) and c (2%G/2 mm) passing rates compar-

98.2  2.0%. and 93.8  5.7% respectively. The only test case fall-

ing the Calculator to Pinnacle were 99.0  1.0% and 97.5  2.4%,

ing below the c (3%G/2 mm) 95% agreement level (91.8%) was again

respectively. The corresponding ranges are 96.3 to 100% and 91.6

the 6 MV IMRT Anal plan. To clearly demonstrate the predominant

to 99.7% respectively. The frequency distributions are shown in

areas of failure, representative transverse and coronal cross-sections

Fig. 6. The three instances with the c(2%G/2mm) passing rates

for that plan are shown in Fig. 5 A and D, with the highlighted pixels

below 95% are all associated with higher energies on the H&N data-

representing the areas of 2%G/2 mm analysis failure. The failing pix-

set, which is unlikely to be seen in practice. Of note, the patterns of

els are largely concentrated in the lower dose areas peripheral to, or

c (2%G/2 mm) analysis failure against ACPDP for the 6 MV IMRT

in between the targets. The rest of the ACPDP doses for both

Anal plan are visually similar between the Calculator and ACPDP

VMAT and IMRT plans agreed with the Calculator for 96.4% of the

(Fig. 5). Not surprisingly the 2%G/2 mm gamma passing rate

points or better (3%G/2mm).

between the Calculator and TPS is 99.1%.
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F I G . 5 . Graphical representation of the c
(2%G/2 mm) comparison for the 6X Anal
IMRT plan between the Calculator and
ACPDP (left column) and Pinnacle vs.
ACPDP (right column). The highlighted
pixels where the gamma analysis fails are
overlaid on the dose map. The targets are
also shown. The transverse cuts (a), (b) are
taken superiorly to demonstrate the areas
of failure between the irradiated nodal
chains. The coronal cuts (c), (d) are 2 cm
posterior to the midline, where both the
primary and secondary targets are
prominently present.

(a)

(b)

(c)

(d)
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T A B L E 1 Gamma analysis passing rates comparing the Calculator
to Pinnacle on the Guideline 5a Lung dataset.
c-Analysis passing rate (%)
Non-HCS

F I G . 6 . Frequency distribution of the c-analysis passing rates
comparing the Calculator to Pinnacle on the patient datasets for
Guideline 5a test cases, excluding the Lung (all energies). N = 18.

HCS

Energy/plan

2%G/2 mm

3%G/2 mm

6 MV-VMAT

99.4

100.0

2%G/ 2mm

3%G/ 2mm

6 MV-IMRT

98.6

99.8

10 MVFFFVMAT

93.9

98.9

10 MVFFFIMRT

94.2

98.6

15 MV-VMAT

82.9

93.4

82.8

92.4

15 MV-IMRT

89.9

96.3

89.0

95.5

the c (3%G/2 mm) analyses for 98.5% (no HCS) and 97.6% (with
HCS) of the voxels. Subsequent comparisons with MC are presented
in Table 3. The Calculator without the HCS correction showed the
best overall agreement with MC by gamma analysis, as well as the

3.G | The calculator vs. primary TPS (lung)

target dose-volume histogram (DVH) agreement. On the other hand,
the Pinnacle lung DVHs were the closest to MC.

The agreement level between the Calculator and Pinnacle for the
Lung plan is energy-, calculation mode-, and dataset-dependent,
which necessitates a more detailed discussion. As can be seen in

4 | DISCUSSION

Table 1, passing rates on the Guideline 5a Lung dataset decrease as
the beam energy increases, which is particularly clear with the 2%

The calculator was put through a series of tests representing a sub-

dose–error threshold. The HCS correction applied to the 15 MV

set of those required for commissioning of a primary TPS dose

plans did not lead to an improvement. The data for the same plans

engine.23,38 The mean IC point dose error in the homogeneous

recalculated on the Thorax phantom are presented in Table 2. Unlike

phantoms is well below the 1.5% expectation.23,39 According to the

with the original dataset, the improvement in agreement with Pinna-

forthcoming recommendation on IMRT QA criteria, 95% of the

cle due to the HCS correction is substantial. However, that by itself

points on a homogeneous phantom passing the 3%G/2 mm/10%

does not prove that the HCS correction leads to more accurate

gamma analysis should constitute the tolerance limit, with the action

results. A comparison with a deﬁnitive standard, such as an MC cal-

limit set at 90% (private communication). While no compelling data

culation, is necessary. Such analysis was performed for a 5-beam

exist to suggest that 3%/2 mm criteria hold an advantage in sensitiv-

15 MV 3D plan. Pinnacle and the Calculator were in agreement by

ity/speciﬁcity over 3%/3 mm, reducing the distance-to-agreement
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T A B L E 2 Gamma analysis passing rates comparing the Calculator
to Pinnacle for the same plans as in Table 1 but recalculated on the
Thoracic phantom.
c-Analysis passing rate (%)
Non-HCS
2%G/2 mm

3%G/2 mm

6 MV-VMAT

99.6

100.0

6 MV-IMRT

98.8

99.8

10 MVFFFVMAT

92.0

98.6

10 MVFFFIMRT

90.0

97.7

15 MVVMAT

76.4

15 MVIMRT

81.9

2% dose–error threshold is pushing the accuracy of diode arrays.
Overall, considering a generic beam model used in the Calculator,
the demonstrated level of agreement on the homogeneous or mildly
inhomogeneous datasets should be considered satisfactory.
The situation is more complicated in the thoracic region. The

HCS

Energy/plan

ET AL.

2%G/2 mm

3%G/2 mm

slab geometry model indicates that for the lower energies (6 and
10 MV), the difference between Pinnacle and the Calculator PDDs
at the tissue/lung interfaces is minimal and both are close to MC.
However, the differences were noticed for 15 MV, with the HCScorrected Calculator PDD being closer to Pinnacle and MC than
the uncorrected data. But that did not translate into a better overall agreement between Pinnacle and the Calculator on the Guide-

86.1

90.8

97.2

line 5a Lung dataset for modulated plans (93–96% for c (3%G/
2 mm)). The plans were then projected on the Thorax phantom,

89.6

90.9

95.8

which contains better deﬁned, sharp interfaces between 0.21 g/cm3
and ~1 g/cm3 densities. In that conﬁguration, the HCS-corrected
Calculator showed substantial improvement in agreement with Pin-

T A B L E 3 Gamma analysis passing rates comparing MC to Pinnacle
and the Calculator (with and without the HCS correction) for the
15 MV 3D plan on the Thoracic phantom.

nacle for the modulated plans (Table 2). While Pinnacle was widely
tested in lung, it cannot be considered the standard and in fact has
been shown to be rather inaccurate in certain situations.34 Unfortunately, we did not have the ability to recalculate the modulated

c-Analysis passing rate (%)

plans with MC. However, a ﬁve-ﬁeld 15 MV 3D plan was comMC vs.
calculator (HCS)

pared with MC on the Thorax phantom. The best overall agreement

MC vs. Pinnacle

MC vs.
calculator (no HCS)

2%G/2
mm

3%G/2
mm

2%G/2
mm

3%G/2
mm

2%G/2
mm

3%G/2
mm

culator dose. The nature of the HCS correction – changing the CT

87.1

92.1

95.7

97.4

92.1

94.9

geneities but does not improve accuracy in all situations. We there-

with MC in this case was observed for the standard (no HCS) Caldataset densities - is nonphysical. It was optimized for slab inhomofore

cannot

recommend

its

routine

use

without

further

investigation. On balance, this is largely an academic point. The cortolerance to 2 mm appears intuitive, given that recommended dis-

rection makes the most difference for the SBRT-type lung treat-

tance-type tolerances in TG-14240 for IMRT machines are 1 to

ments, the precise situation where the use of energies above

2 mm.

10 MV should be rather limited.

Comparisons between the Calculator and direct measurements

There is no guidance document yet on IMRT dose distribution

by the diode array indicated that the Calculator performed at the

veriﬁcation by independent calculation, with or without some empiri-

accuracy level that could be expected for routine patient-speciﬁc QA

cal input. In the meantime, it seems reasonable to apply the forth-

from a primary TPS. Similar results were seen for the volumetric

coming

comparisons on the Guideline 5a patient datasets (excluding the

However, there are additional uncertainties related to calculating

Lung) with measurement-guided dose reconstruction. In both series

dose in lung, and appropriate criteria need to be developed, perhaps

of experiments only some Anal plans exhibited less than 95% (but

such as the varying action limits based on the algorithm similarity

above 90%) passing rates at the 3%G/2 mm level. This is one of the

and case complexity established for secondary checks in non-IMRT

most challenging plan classes, featuring large bifurcating targets that

radiotherapy.2

experimental

veriﬁcation

criteria

in

most

situations.

require a rather high number of segments, thus challenging the dose

Finally, we must point out that subtle dose differences could

engine model accuracy under the MLC leaves and in the penumbra.

stem from the way the different algorithms calculate or report dose

As such, these types of cases often exhibit the largest dosimetric

to different tissue types.41 For example, both Pinnacle and the Cal-

discrepancies regardless of the dose calculation algorithm. The 6 MV

culator determine the tissue type from their CT to density conver-

Anal IMRT plan’s pattern of pixels failing the more stringent 2%G/

sion tables, using the mass and electron densities, respectively. This

2 mm gamma analysis against ACPDP (Fig. 5) is similar between the

tissue assignment is then used to look up the appropriate mass

Calculator and TPS. The most challenging are the low dose areas

energy absorption coefﬁcient for TERMA calculations. The Pinnacle

outside and in particular in between the targets, indicating imperfect

assignment table does not include water, while in the Calculator CT

dose calculations at the voxels spending a relatively large proportion

voxels corresponding to approximately unit density would resolve to

of time under the closed MLC leaves. A qualitatively similar pattern

water. This difference in dose reporting could potentially lead to up

of failure is observed with the Delta4, increasing the likelihood that

to ~1% error even on an ideal unit-density phantom, and is hard to

the observed errors are real rather than a measurement artifact, as a

control for a patient CT dataset.

AHMED
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5 | CONCLUSIONS
We benchmarked a fast GPU-based independent S/C dose engine
that produces 3D dose distributions on the patient CT datasets for
comparison with the TPS IMRT/VMAT calculations. Comparisons
with the ion chamber, diode array measurements, and measurementguided 3D dose reconstruction for challenging datasets reveal the
accuracy level expected in routine patient-speciﬁc testing [≥ 95% c
(3%G/2 mm) passing rates in most cases]. Direct comparison with
the Pinnacle TPS on the realistic CT datasets showed similar agreement. The alternative additional heterogeneity correction can change
the dose noticeably in some situations with the higher energy beam
(15 MV). However, this correction does not always result in the
more accurate dose calculation and should be used with caution.
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